Zum Hauptinhalt springen
DecodeStocks
Stock Screener
Portfolio & Watchlist
Calendar
News
Search stock symbol
Let's go
Screener
My Stocks
Calendar
News
DMAA
CIK: 2028614
Drugs Made In America Acquisition Corp.
United States
Financials
Fundamentals Score
Metrics score locked — part of Premium
Available with Premium
/ 100
Premium
Overview
AI Analysis
Revenue & Profit
Deep Analysis
Balance Sheet
Income Statement
Cash Flow Statement
Overview
Details
Overview
Details
Details
Annual
Quarterly
Annual
Quarterly
FY25
FY25
Operating cashflow
(positive)
millions USD
FY25
FY25:
−0.54
Investing cashflow
millions USD
FY25
FY25:
−231
Financing cashflow
millions USD
FY25
FY25:
232
All amounts in millions USD
Data source:
SEC EDGAR